Zobrazeno 1 - 10 of 115 pro vyhledávání: '"Laura L Otero"'
1
Tissue factor as a novel marker for detection of circulating cancer cells
Autor: Gabri, Daniel E. Gomez, Mónica a. Castro, Gabriela Cinat, Laura L Otero, D F Alonso
Publikováno v: Biomarkers. 16:58-64
Tissue factor (TF) is a molecular marker that is up-regulated in cancer cells and aids tumoral dissemination. Our purpose was to develop a nested RT-PCR strategy against TF for detecting blood-borne tumour cells. Our method detected TF expression in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b52f23c65d8b5304c50a3a90d984221
https://doi.org/10.3109/1354750x.2010.533282
Zobrazit plný text záznamu
2
Detección molecular de enfermedad mínima residual en melanoma y otros tumores sólidos Molecular detection of minimal residual disease in melanoma and solid tumors
Autor: Valeria Vázquez, Laura L. Otero, Viviana E. Laurent, Mariano R. Gabri, Daniel E. Gómez, Daniel F. Alonso
Publikováno v: Medicina (Buenos Aires), Vol 69, Iss 1, Pp 181-190 (2009)
La disponibilidad de métodos altamente sensibles y específicos para la detección de enfermedad mínima residual en pacientes con tumores sólidos podría tener importantes consecuencias pronósticas y terapéuticas. Uno de los métodos más usados
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::65460d30ba0534003dd4a474929dfa98
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802009000100011
Zobrazit plný text záznamu
3
Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides
Autor: Valeria I, Segatori, Laura L, Otero, Luis Enrique, Fernandez, Daniel E, Gomez, Daniel F, Alonso, Mariano R, Gabri
Publikováno v: In vivo (Athens, Greece). 26(4)
Cancer vaccines are designed to modulate immunological responses against tumor cells through the presentation of tumor antigens.The mouse mRNA of the cytidine monophospho-N-acetylneuraminic acid hydroxylase (Cmah) gene, the enzyme that catalyzes the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::201c18be524f3bdb2f4687ad287373fd
https://pubmed.ncbi.nlm.nih.gov/22773575
Zobrazit plný text záznamu
4
Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma
Autor: Viviana E, Laurent, Laura L, Otero, Valeria, Vazquez, Sandra, Camarero, Mariano R, Gabri, María, Labraga, María T G, De Dávila, Guillermo L, Chantada, Daniel F, Alonso
Publikováno v: Molecular medicine reports. 3(2)
Extraocular dissemination is the main cause of death in patients with retinoblastoma (RB) in developing countries, and there are few molecular markers that are useful for the evaluation of minimal disseminated disease. The GD2 ganglioside is known to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::923a076b8de63dc4592b718168751d1f
https://pubmed.ncbi.nlm.nih.gov/21472230
Zobrazit plný text záznamu
5
Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines
Autor: Mariano R. Gabri, Daniel F. Alonso, Daniel E. Gomez, Laura L Otero
Publikováno v: Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 28, Iss 1, p 146 (2009)
Background Carbohydrates embedded in the plasma membrane are one of the main actors involved in the communication of cells with the microenvironment. Neuraminic sialic acids are glycocalyx sugars that play important roles in the modulation of maligna
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17fb897ca89fef85106d4d3625eda85c
https://pubmed.ncbi.nlm.nih.gov/19951433
Zobrazit plný text záznamu
6
[Molecular detection of minimal residual disease in melanoma and solid tumors]
Autor: Valeria, Vázquez, Laura L, Otero, Viviana E, Laurent, Mariano R, Gabri, Daniel E, Gómez, Daniel F, Alonso
Publikováno v: Medicina. 69(1 Pt 2)
The availability of highly sensitive and specific methods for the detection of minimal residual disease in patients with solid tumors may have important prognostic and therapeutic implications. One of the most widely used methods for the molecular de
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8aa06a2932e50e4a506dcec216b7c0a9
https://pubmed.ncbi.nlm.nih.gov/19414304
Zobrazit plný text záznamu
8
Circulating tyrosinase mRNA detection in a preclinical xenograft mouse melanoma model and in advanced melanoma patients
Autor: Mónica a. Castro, Laura L Otero, Gabriela Cinat, Mariano R. Gabri, V. Vazquez, Daniel E. Gomez, D F Alonso
Publikováno v: Journal of Clinical Oncology. 26:22204-22204
22204 Background: Although it is still under debate, molecular detection of circulating Tyrosinase is believed to be a good prognostic marker for melanoma progression. Methods: We have designed hig...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::33d95747cc3ee0f70ba599691972ba90
https://doi.org/10.1200/jco.2008.26.15_suppl.22204
Zobrazit plný text záznamu
9
Akademický článek
The proteomic signature of circulating extracellular vesicles following intracerebral hemorrhage: Novel insights into mechanisms underlying recovery.
Autor: Casado-Fernández L; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Laso-García F; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Piniella D; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain; Faculty of Medicine, Universidad Alfonso X el Sabio, Villanueva de la Cañada, Madrid, Spain., Gómez-de Frutos MC; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain; Faculty of Health Sciences - HM Hospitals, University Camilo José Cela. Villanueva de la Cañada, Madrid, España; Instituto de Investigación Sanitaria HM Hospitales, 28015 Madrid, Spain., Otero-Ortega L; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Bravo SB; Proteomic Unit, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Fuentes-Gimeno B; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Docando F; Electron Microscopy Unit, Scientific-Technical Central Units, Institute of Health Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain., Alonso-López E; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Ruiz-Ares G; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Rodríguez-Pardo J; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Rigual R; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., de Celis-Ruiz E; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Hervás C; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Díez-Tejedor E; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain., Gutiérrez-Fernández M; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain. Electronic address: mgutierrezfernandez@salud.madrid.org., Alonso de Leciñana M; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Center, Neurology and Cerebrovascular Disease Group, Neuroscience Area Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital - Universidad Autónoma de Madrid), Madrid, Spain. Electronic address: malecinanacases@salud.madrid.org.
Publikováno v: Neurobiology of disease [Neurobiol Dis] 2024 Oct 15; Vol. 201, pp. 106665. Date of Electronic Publication: 2024 Sep 12.
Zobrazit plný text záznamu
10
Akademický článek
Differential Protein Expression in Extracellular Vesicles Defines Treatment Responders and Non-Responders in Multiple Sclerosis.
Autor: Torres Iglesias G; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., López-Molina M; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Botella L; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Laso-García F; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Chamorro B; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Fernández-Fournier M; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Puertas I; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Bravo SB; Proteomics Unit, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., Alonso-López E; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Díez-Tejedor E; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Gutiérrez-Fernández M; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain., Otero-Ortega L; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), 28046 Madrid, Spain.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 06; Vol. 25 (19). Date of Electronic Publication: 2024 Oct 06.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje